Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/90709
Full metadata record
DC FieldValueLanguage
dc.creatorRui Miguel Pedrosa Pereira
dc.date.accessioned2022-09-10T12:00:42Z-
dc.date.available2022-09-10T12:00:42Z-
dc.date.issued2016-07-11
dc.date.submitted2017-01-16
dc.identifier.othersigarra:173162
dc.identifier.urihttps://hdl.handle.net/10216/90709-
dc.language.isopor
dc.rightsopenAccess
dc.subjectCiências médicas e da saúde
dc.subjectMedical and Health sciences
dc.titleSafety of Anti-TNF Therapies in Immune-Mediated Inflammatory Diseases: Focus on Infections and Malignancy
dc.typeDissertação
dc.contributor.uportoInstituto de Ciências Biomédicas Abel Salazar
dc.identifier.tid201621908
dc.subject.fosCiências médicas e da saúde
dc.subject.fosMedical and Health sciences
thesis.degree.disciplineMestrado Integrado em Medicina
thesis.degree.grantorInstituto de Ciências Biomédicas Abel Salazar
thesis.degree.grantorUniversidade do Porto
thesis.degree.level1
Appears in Collections:ICBAS - Dissertação

Files in This Item:
File Description SizeFormat 
173162.pdfSafety of Anti-TNF Therapies in Immune-Mediated Inflammatory Diseases: Focus on Infections and Malignancy5.41 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.